The complexity of sunitinib dosing in renal cell cancer patients

Por Desar, Ingrid M.E., Mulder, Sasja F., Mulders, Peter F.A., van Herpen, Carla M.L.
Publicado no Transl Androl Urol (2012)

The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma

Por Thijs, Anna Maria J., Tack, Cees J., van der Graaf, Winette T. A., Rongen, Gerard A., van Herpen, Carla M. L.
Publicado no Br J Clin Pharmacol (2016)

Thermal distribution, physiological effects and toxicities of extracorporeally induced whole‐body hyperthermia in a pig model

Por Lassche, Gerben, Frenzel, Tim, Mignot, Marcel H., Jonker, Marianne A., van der Hoeven, Johannes G., van Herpen, Carla M. L., Scheffer, Gert Jan
Publicado no Physiol Rep (2020)

Caregivers’ burden and fatigue during and after patients’ treatment with concomitant chemoradiotherapy for locally advanced head and neck cancer: a prospective, observational pilot...

Por Langenberg, Simone M. C. H., van Herpen, Carla M. L., van Opstal, Claudia C. M., Wymenga, Anke N. M., van der Graaf, Winette T. A., Prins, Judith B.
Publicado no Support Care Cancer (2019)

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors

Por Desar, Ingrid M. E., Gilles, Rozemarie, van Herpen, Carla M. L., Timmer-Bonte, Anja (J.) N. H., Cantarini, Mireille V., van der Graaf, Winette T. A., Oyen, Wim J. G.
Publicado em 2012

Theranostic applications of antibodies in oncology

Por Fleuren, Emmy D.G., Versleijen-Jonkers, Yvonne M.H., Heskamp, Sandra, van Herpen, Carla M.L., Oyen, Wim J.G., van der Graaf, Winette T.A., Boerman, Otto C.
Publicado no Mol Oncol (2014)

(68)Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study

Por van Boxtel, Wim, Lütje, Susanne, van Engen-van Grunsven, Ilse C.H., Verhaegh, Gerald W., Schalken, Jack A., Jonker, Marianne A., Nagarajah, James, Gotthardt, Martin, van Herpen, Carla M.L.
Publicado no Theranostics (2020)

Psychological aspects in patients with advanced cancer receiving lifelong systemic treatment: protocol for a scoping review

Por Kolsteren, Evie E M, Deuning-Smit, Esther, Prins, Judith B, van der Graaf, Winette T A, van Herpen, Carla M L, Lebel, Sophie, Thewes, Belinda, Kwakkenbos, Linda, Custers, José A E
Publicado no BMJ Open (2021)

Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib

Por Lankheet, Nienke A. G., Desar, Ingrid M. E., Mulder, Sasja F., Burger, David M., Kweekel, Dinemarie M., van Herpen, Carla M. L., van der Graaf, Winette T. A., van Erp, Nielka P.
Publicado no Br J Clin Pharmacol (2017)

Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR st...

Por Driessen, Chantal M. L., Groenewoud, Johannes M. M., de Boer, Jan Paul, Gelderblom, Hans, van der Graaf, Winette T. A., Prins, Judith B., Kaanders, Johannes H. A. M., van Herpen, Carla M. L.
Publicado no Support Care Cancer (2017)

Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome

Por Prinsen, Hetty, de Vries, I Jolanda M, Torensma, Ruurd, Pots, Jeanette M, Mulder, Sasja F, van Herpen, Carla M L, Elving, Lammy D, Bleijenberg, Gijs, Stelma, Foekje F, van Laarhoven, Hanneke W M
Publicado em 2012

Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin...

Por Ham, Janneke C., van Meerten, Esther, Fiets, W. Edward, Beerepoot, Laurens V., Jeurissen, Frank J. F., Slingerland, Marije, Jonker, Marianne A., Husson, Olga, van der Graaf, Winette T. A., van Herpen, Carla M. L.
Publicado no Head Neck (2020)

Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey

Por de Heus, Eline, Engelen, Vivian, Dingemans, Irene, Richel, Carol, Schrieks, Marga, van der Zwan, Jan Maarten, Besselink, Marc G., van Berge Henegouwen, Mark I., van Herpen, Carla M. L., Duijts, Saskia F. A.
Publicado no Orphanet J Rare Dis (2021)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands

Por van der Linden, Naomi, Buter, Jan, Pescott, Chris P., Lalisang, Roy I., de Boer, Jan Paul, de Graeff, Alexander, van Herpen, Carla M. L., Baatenburg de Jong, Robert J., Uyl-de Groot, Carin A.
Publicado no Eur Arch Otorhinolaryngol (2015)

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters

Por Caetano-Pinto, Pedro, Jamalpoor, Amer, Ham, Janneke, Goumenou, Anastasia, Mommersteeg, Monique, Pijnenburg, Dirk, Ruijtenbeek, Rob, Sanchez-Romero, Natalia, van Zelst, Bertrand, Heil, Sandra G., Jansen, Jitske, Wilmer, Martijn J., van Herpen, Carla M. L., Masereeuw, Rosalinde
Publicado no Mol Pharm (2017)

Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations

Por Willemsen, Annelieke E. C. A. B., Krausz, Sarah, Ligtenberg, Marjolijn J. L., Grünberg, Katrien, Groen, Harry J. M., Voest, Emile E., Cuppen, Edwin P. J. G., van Laarhoven, Hanneke W. M., van Herpen, Carla M. L.
Publicado no Br J Cancer (2019)

Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane

Por Willemsen, Annelieke E. C. A. B., Tol, Jolien, van Erp, Nielka P., Jonker, Marianne A., de Boer, Maaike, Meek, Bob, de Jong, Paul C., van Moorsel, Coline, Gerritsen, Winald R., Grutters, Jan C., van Herpen, Carla M. L.
Publicado no Target Oncol (2019)

Merkel Cell Carcinoma: New Trends

Por Zwijnenburg, Ellen M., Lubeek, Satish F.K., Werner, Johanna E.M., Amir, Avital L., Weijs, Willem L.J., Takes, Robert P., Pegge, Sjoert A.H., van Herpen, Carla M.L., Adema, Gosse J., Kaanders, Johannes H. A. M.
Publicado no Cancers (Basel) (2021)

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

Por Van Wigcheren, Glenn F., De Haas, Nienke, Mulder, Tom A., Horrevorts, Sophie K., Bloemendal, Martine, Hins-Debree, Simone, Mao, Yumeng, Kiessling, Rolf, van Herpen, Carla M.L., Flórez-Grau, Georgina, Hato, Stanleyson V., De Vries, I. Jolanda M.
Publicado no Oncoimmunology (2021)

Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade

Por Lassche, Gerben, Tada, Yuichiro, van Herpen, Carla M. L., Jonker, Marianne A., Nagao, Toshitaka, Saotome, Takashi, Hirai, Hideaki, Saigusa, Natsuki, Takahashi, Hideaki, Ojiri, Hiroya, van Engen-Van Grunsven, Adriana C. H., Schalken, Jack A., Fushimi, Chihiro, Verhaegh, Gerald W.
Publicado no Cancers (Basel) (2021)